Skip to main content
Oculis Holding AG logo

Oculis Holding AG — Investor Relations & Filings

Ticker · OCS ISIN · CH1242303498 LEI · 5067005370C2KK324336 IC Manufacturing
Open in API
Filings indexed 321 across all filing types
Latest filing 2025-02-08 Director's Dealing
Country CH Switzerland
Listing IC OCS

About Oculis Holding AG

https://www.oculis.com/

Oculis Holding AG is a global, clinical-stage biopharmaceutical company focused on developing innovative therapies for ophthalmic and neuro-ophthalmic diseases with significant unmet medical needs. The company's pipeline aims to transform current treatment paradigms. Key candidates include OCS-01, a topical eye drop using the proprietary OPTIREACH® technology, investigated as a potential first non-invasive treatment for Diabetic Macular Edema (DME). Another lead asset is Privosegtor, a novel peptoid small molecule being developed as a neuroprotective therapy for optic neuropathies such as Acute Optic Neuritis. The pipeline also features Licaminlimab, an anti-TNFα eye drop candidate for treating Dry Eye Disease.

Recent filings

Filing Released Lang Actions
Notification of managers transaction - Sylvia Cheung.pdf
Director's Dealing Classification · 100% confidence The document is a standard template for the notification and public disclosure of transactions by persons discharging managerial responsibilities (PDMRs), specifically detailing the vesting of earnout shares for the CFO of Oculis Holding AG. This falls under the category of Director's Dealing (DIRS), which covers insider trades and transactions by company executives.
2025-02-08 English
Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated
Director's Dealing Classification · 95% confidence The document is a short announcement (690 characters) titled 'Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated'. It explicitly states that the notifications are 'attached' and refers to the vesting of shares. While it concerns director dealings, the document itself is a brief notification/announcement of these filings rather than the detailed transaction report itself. Following the 'Menu vs Meal' rule, this is classified as a Report Publication Announcement.
2025-02-08 English
Oculis Publishes Notifications of T..
Director's Dealing Classification · 100% confidence The document is titled "Template for notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them." It details a transaction involving shares (Vesting of earnout shares) by an individual associated with the issuer (Oculis Holding AG) and a related entity (Sjónarhóll Fjárfestingar ehf). This structure and content directly correspond to regulatory filings concerning insider transactions or director's dealings, specifically mandated by regulations like MAR (Market Abuse Regulation) in the EU context, which require disclosure of transactions by PDMRs. Among the provided codes, 'Director's Dealing (Code: DIRS)' is the most appropriate classification for reports detailing personal share transactions by company directors and executives (insider trades).
2025-02-07 English
Oculis updates share capital for its existing at-the-market offering program
Share Issue/Capital Change Classification · 100% confidence The document announces an update to the company's share capital following the issuance of new shares related to an at-the-market (ATM) offering program. It details the number of shares issued, the impact on treasury shares, and references the underlying sales agreement. This falls under the category of share capital changes and issuance announcements.
2025-01-31 English
Oculis updates share capital for it..
Share Issue/Capital Change Classification · 99% confidence The document explicitly announces an update to the company's share capital, detailing the issuance of 2,500,000 registered ordinary shares which will be held as treasury shares, related to an existing at-the-market (ATM) offering program. This action directly concerns the company's share structure and capital changes. This aligns perfectly with the definition of 'Share Issue/Capital Change' (SHA), which covers new share issues and capital structure changes. It is not a general earnings release (ER), a full annual report (10-K), or a simple dividend notice (DIV).
2025-01-31 English
Notification of Major Changes in Voting Rights - Íslandsbanki 21 Jan 2025.pdf
Major Shareholding Notification Classification · 100% confidence The document is a standard 'flöggun' (flagging) form, which is the Icelandic regulatory term for a Major Shareholding Notification. It explicitly references 'lög nr. 20/2021 um upplýsingaskyldu útgefenda verðbréfa og flöggunarskyldu' (Act on disclosure obligations of issuers of securities and flagging obligations). It details a change in shareholding percentage (falling below 5%) for OCULIS Holding by Íslandsbanki hf. This fits the definition of a Major Shareholding Notification (MRQ).
2025-01-21 Icelandic

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.